Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.
- DOI
- 10.1016/j.bcp.2026.118180
- Published
- 2026 Sep
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118180,
title = {Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.},
author = {Valencia I and Vidal-Gómez X and San Hipólito-Luengo Á and Villacampa A and Shamoon L and Cuadrado-Gómez A and Berlanas-Vicente D and de la Cuesta F and Moncada S and Gomez-Cerezo JF and Sánchez-Ferrer CF and Martínez MC and Andriantsitohaina R and Peiró C},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118180},
url = {https://doi.org/10.1016/j.bcp.2026.118180}
}RIS
TY - JOUR TI - Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation. AU - Valencia I AU - Vidal-Gómez X AU - San Hipólito-Luengo Á AU - Villacampa A AU - Shamoon L AU - Cuadrado-Gómez A AU - Berlanas-Vicente D AU - de la Cuesta F AU - Moncada S AU - Gomez-Cerezo JF AU - Sánchez-Ferrer CF AU - Martínez MC AU - Andriantsitohaina R AU - Peiró C PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118180 UR - https://doi.org/10.1016/j.bcp.2026.118180 ER -
APA
I, V., X, V., Á, S. H., A, V., L, S., A, C., D, B., F, D. L. C., S, M., JF, G., CF, S., MC, M., R, A., & C, P. (2026). Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammation.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118180
Source records
- pubmed · retrieved 2026-09-26T21:01:40.998Z